Citius Pharmaceuticals, Inc. (CTXR)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Citius Pharmaceuticals, Inc. (CTXR)
Company Performance

Current Price

as of Oct 16, 2024

$0.41

P/E Ratio

N/A

Market Cap

$74.46M

Description

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

Metrics

Overview

  • HQCranford, NJ
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerCTXR
  • Price$0.412+10.13%

Trading Information

  • Market Cap$74.46M
  • Float93.18%
  • Average Daily Volume (1m)1,177,413
  • Average Daily Volume (3m)1,543,657
  • EPS-$0.24

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$10.57M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$10.58M
  • EV$84.49M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B0.87
Documents